Compared with the FOXK1-overexpressing cells, the FHL2 downregulation observed in FOXK1-overexpressing cells led to a significant reduction of visible tumours in the liver and lung, which correlated to a lower number of metastasis loci (Figure 6d). This evidence concerns the gene FHL2 and neoplasm.